Cargando…
Precision radiotherapy for non-small cell lung cancer
Precision medicine is becoming the standard of care in anti-cancer treatment. The personalized precision management of cancer patients highly relies on the improvement of new technology in next generation sequencing and high-throughput big data processing for biological and radiographic information....
Autores principales: | Yang, Wen-Chi, Hsu, Feng-Ming, Yang, Pan-Chyr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374898/ https://www.ncbi.nlm.nih.gov/pubmed/32693792 http://dx.doi.org/10.1186/s12929-020-00676-5 |
Ejemplares similares
-
Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors
por: Hsu, Chia-Lin, et al.
Publicado: (2012) -
Local ablative radiotherapy for oligometastatic non-small cell lung cancer
por: Suh, Yang-Gun, et al.
Publicado: (2019) -
Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
por: Lu, Shao-Lun, et al.
Publicado: (2016) -
Role of the cGAS-STING pathway in radiotherapy for non-small cell lung cancer
por: Yang, Chunsheng, et al.
Publicado: (2023) -
The evolving role of radiotherapy in non-small cell lung cancer
por: Brown, Sean, et al.
Publicado: (2019)